Found: 12
Select item for more details and to access through your institution.
Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-15238-y
- By:
- Publication type:
- Article
Durability and Immunogenicity of Neutralizing Antibodies Response Against Omicron Variants After Three Doses of Subunit SARS-CoV-2 Vaccine MVC-COV1901: An Extension to an Open-Label, Dose-Escalation Phase 1 Study.
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 4, p. 1493, doi. 10.1007/s40121-022-00652-6
- By:
- Publication type:
- Article
Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults: A Phase I, Prospective, Randomized, Open-Labeled Study.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1798, doi. 10.3390/vaccines11121798
- By:
- Publication type:
- Article
A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 18, doi. 10.3390/vaccines11010018
- By:
- Publication type:
- Article
Prescribing antibiotics for children with dengue infection in Taiwan: who are at risk and who are high prescribers?
- Published in:
- International Journal for Quality in Health Care, 2024, v. 36, n. 2, p. 1, doi. 10.1093/intqhc/mzae052
- By:
- Publication type:
- Article
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00589-4
- By:
- Publication type:
- Article
Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 11, p. 1899, doi. 10.1093/cid/ciab711
- By:
- Publication type:
- Article
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-88283-8
- By:
- Publication type:
- Article
Clinical Validation of a Deep Learning-Based Software for Lumbar Bone Mineral Density and T-Score Prediction from Chest X-ray Images.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 12, p. 1208, doi. 10.3390/diagnostics14121208
- By:
- Publication type:
- Article
Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.
- Published in:
- PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0272594
- By:
- Publication type:
- Article
Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 9, p. 1562, doi. 10.1093/infdis/jiac153
- By:
- Publication type:
- Article
Population-based assessment of factors influencing antibiotic prescribing for adults with dengue infection in Taiwan.
- Published in:
- PLoS Neglected Tropical Diseases, 2022, v. 16, n. 2, p. 1, doi. 10.1371/journal.pntd.0010198
- By:
- Publication type:
- Article